NAVIDEA BIOPHARMACEUTICALS, INC. - FORM 10-K - EX-32.1 - CERTIFICATION - March 31, 2017

Attached files

file filename
EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - NAVIDEA BIOPHARMACEUTICALS, INC.navb_ex21-1.htm
EX-32.2 - CERTIFICATION - NAVIDEA BIOPHARMACEUTICALS, INC.navb_ex32-2.htm
EX-31.2 - CERTIFICATION - NAVIDEA BIOPHARMACEUTICALS, INC.navb_ex31-2.htm
EX-31.1 - CERTIFICATION - NAVIDEA BIOPHARMACEUTICALS, INC.navb_ex31-1.htm
EX-24.1 - POWER OF ATTORNEY - NAVIDEA BIOPHARMACEUTICALS, INC.navb_ex24-1.htm
EX-23.2 - CONSENTS OF EXPERTS AND COUNSEL - NAVIDEA BIOPHARMACEUTICALS, INC.navb_ex23-2.htm
EX-23.1 - CONSENTS OF EXPERTS AND COUNSEL - NAVIDEA BIOPHARMACEUTICALS, INC.navb_ex23-1.htm
EX-3.1 - ARTICLES OF INCORPORATION / BYLAWS - NAVIDEA BIOPHARMACEUTICALS, INC.navb_ex3-1.htm
10-K - NAVIDEA BIOPHARMACEUTICALS FORM 10-K - NAVIDEA BIOPHARMACEUTICALS, INC.navb_10k.htm
 
Exhibit 32.1
 
CERTIFICATION OF PERIODIC FINANCIAL REPORT PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002, 18 U.S.C. SECTION 1350
 
The undersigned hereby certifies that he is the duly appointed and acting Chief Executive Officer of Navidea Biopharmaceuticals, Inc. (the “Company”) and hereby further certifies as follows:
 
(1) The periodic report containing financial statements to which this certificate is an exhibit fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
(2) The information contained in the periodic report to which this certificate is an exhibit fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
In witness whereof, the undersigned has executed and delivered this certificate as of the date set forth opposite his signature below.
 
March 31, 2017
/s/ Michael M. Goldberg
 
Michael M. Goldberg, M.D.
 
President and Chief Executive Officer
    
 
 

NAVIDEA BIOPHARMACEUTICALS, INC. Reports